188 related articles for article (PubMed ID: 30650425)
1. Downregulation of SPARC Is Associated with Epithelial-Mesenchymal Transition and Low Differentiation State of Biliary Tract Cancer Cells.
Aghamaliyev U; Gaitantzi H; Thomas M; Simon-Keller K; Gaiser T; Marx A; Yagublu V; Araos J; Cai C; Valous NA; Halama N; Kiesslich T; Ebert M; Grützmann R; Rückert F; Breitkopf-Heinlein K
Eur Surg Res; 2019; 60(1-2):1-12. PubMed ID: 30650425
[TBL] [Abstract][Full Text] [Related]
2. RBM38 is involved in TGF-β-induced epithelial-to-mesenchymal transition by stabilising zonula occludens-1 mRNA in breast cancer.
Wu J; Zhou XJ; Sun X; Xia TS; Li XX; Shi L; Zhu L; Zhou WB; Wei JF; Ding Q
Br J Cancer; 2017 Aug; 117(5):675-684. PubMed ID: 28683467
[TBL] [Abstract][Full Text] [Related]
3. Role of crosstalk between interleukin-6 and transforming growth factor-beta 1 in epithelial-mesenchymal transition and chemoresistance in biliary tract cancer.
Yamada D; Kobayashi S; Wada H; Kawamoto K; Marubashi S; Eguchi H; Ishii H; Nagano H; Doki Y; Mori M
Eur J Cancer; 2013 May; 49(7):1725-40. PubMed ID: 23298711
[TBL] [Abstract][Full Text] [Related]
4. A Histone Deacetylase Inhibitor Suppresses Epithelial-Mesenchymal Transition and Attenuates Chemoresistance in Biliary Tract Cancer.
Sakamoto T; Kobayashi S; Yamada D; Nagano H; Tomokuni A; Tomimaru Y; Noda T; Gotoh K; Asaoka T; Wada H; Kawamoto K; Marubashi S; Eguchi H; Doki Y; Mori M
PLoS One; 2016; 11(1):e0145985. PubMed ID: 26726879
[TBL] [Abstract][Full Text] [Related]
5. A novel molecular pathway for Snail-dependent, SPARC-mediated invasion in non-small cell lung cancer pathogenesis.
Grant JL; Fishbein MC; Hong LS; Krysan K; Minna JD; Shay JW; Walser TC; Dubinett SM
Cancer Prev Res (Phila); 2014 Jan; 7(1):150-60. PubMed ID: 24253315
[TBL] [Abstract][Full Text] [Related]
6. SPARC acts as a mediator of TGF-β1 in promoting epithelial-to-mesenchymal transition in A549 and H1299 lung cancer cells.
Sun W; Feng J; Yi Q; Xu X; Chen Y; Tang L
Biofactors; 2018 Sep; 44(5):453-464. PubMed ID: 30346081
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of tumoral and/or peri-tumoral stromal SPARC expressions after surgery in patients with biliary tract cancer.
Nakashima S; Kobayashi S; Sakai D; Tomokuni A; Tomimaru Y; Hama N; Wada H; Kawamoto K; Marubashi S; Eguchi H; Matsuura N; Doki Y; Mori M; Nagano H
J Surg Oncol; 2014 Dec; 110(8):1016-22. PubMed ID: 25155283
[TBL] [Abstract][Full Text] [Related]
8. SPARC accelerates biliary tract cancer progression through CTGF-mediated tumor-stroma interactions: SPARC as a prognostic marker of survival after neoadjuvant therapy.
Takayama H; Kobayashi S; Gotoh K; Sasaki K; Iwagami Y; Yamada D; Tomimaru Y; Akita H; Asaoka T; Noda T; Wada H; Takahashi H; Tanemura M; Doki Y; Eguchi H
J Cancer Res Clin Oncol; 2023 Sep; 149(12):10935-10950. PubMed ID: 37330435
[TBL] [Abstract][Full Text] [Related]
9. BMP-7 fails to attenuate TGF-beta1-induced epithelial-to-mesenchymal transition in human proximal tubule epithelial cells.
Dudas PL; Argentieri RL; Farrell FX
Nephrol Dial Transplant; 2009 May; 24(5):1406-16. PubMed ID: 19056781
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of Treg/Th17 According to Cancer Progression and Modification in Biliary Tract Cancers via Self-Producing Cytokines.
Kinoshita M; Kobayashi S; Gotoh K; Kubo M; Hayashi K; Iwagami Y; Yamada D; Akita H; Noda T; Asaoka T; Takeda Y; Tanemura M; Eguchi H; Urakawa S; Goto K; Maekawa K; Wada H; Mori M; Doki Y
Dig Dis Sci; 2020 Oct; 65(10):2937-2948. PubMed ID: 31853779
[TBL] [Abstract][Full Text] [Related]
11. Secreted Protein Acidic and Rich in Cysteine (SPARC) Enhances Cell Proliferation, Migration, and Epithelial Mesenchymal Transition, and SPARC Expression is Associated with Tumor Grade in Head and Neck Cancer.
Chang CH; Yen MC; Liao SH; Hsu YL; Lai CS; Chang KP; Hsu YL
Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28718842
[TBL] [Abstract][Full Text] [Related]
12. Regulation of the expression of a secreted acidic protein rich in cysteine (SPARC) in human fibroblasts by transforming growth factor beta. Comparison of transcriptional and post-transcriptional control with fibronectin and type I collagen.
Wrana JL; Overall CM; Sodek J
Eur J Biochem; 1991 Apr; 197(2):519-28. PubMed ID: 1709099
[TBL] [Abstract][Full Text] [Related]
13. SPARC downregulation attenuates the profibrogenic response of hepatic stellate cells induced by TGF-β1 and PDGF.
Atorrasagasti C; Aquino JB; Hofman L; Alaniz L; Malvicini M; Garcia M; Benedetti L; Friedman SL; Podhajcer O; Mazzolini G
Am J Physiol Gastrointest Liver Physiol; 2011 May; 300(5):G739-48. PubMed ID: 21311029
[TBL] [Abstract][Full Text] [Related]
14. SPARC expression in tumor microenvironment induces partial epithelial-to-mesenchymal transition of esophageal adenocarcinoma cells via cooperating with TGF-β signaling.
Ma W; Yan Y; Bai S; Zhou Y; Wang X; Feng Z; Li G; Zhou S; Zhang J; Ren J
Cell Biol Int; 2023 Jan; 47(1):250-259. PubMed ID: 36229930
[TBL] [Abstract][Full Text] [Related]
15. SPARC inhibits epithelial cell proliferation in part through stimulation of the transforming growth factor-beta-signaling system.
Schiemann BJ; Neil JR; Schiemann WP
Mol Biol Cell; 2003 Oct; 14(10):3977-88. PubMed ID: 14517312
[TBL] [Abstract][Full Text] [Related]
16. An in vitro model of posterior capsular opacity: SPARC and TGF-beta2 minimize epithelial-to-mesenchymal transition in lens epithelium.
Gotoh N; Perdue NR; Matsushima H; Sage EH; Yan Q; Clark JI
Invest Ophthalmol Vis Sci; 2007 Oct; 48(10):4679-87. PubMed ID: 17898292
[TBL] [Abstract][Full Text] [Related]
17. SPARC regulates TGF-beta1-dependent signaling in primary glomerular mesangial cells.
Francki A; McClure TD; Brekken RA; Motamed K; Murri C; Wang T; Sage EH
J Cell Biochem; 2004 Apr; 91(5):915-25. PubMed ID: 15034927
[TBL] [Abstract][Full Text] [Related]
18. SPARC promotes cathepsin B-mediated melanoma invasiveness through a collagen I/α2β1 integrin axis.
Girotti MR; Fernández M; López JA; Camafeita E; Fernández EA; Albar JP; Benedetti LG; Valacco MP; Brekken RA; Podhajcer OL; Llera AS
J Invest Dermatol; 2011 Dec; 131(12):2438-47. PubMed ID: 21850018
[TBL] [Abstract][Full Text] [Related]
19. Regulation of transformation-sensitive secreted phosphoprotein (SPPI/osteopontin) expression by transforming growth factor-beta. Comparisons with expression of SPARC (secreted acidic cysteine-rich protein).
Wrana JL; Kubota T; Zhang Q; Overall CM; Aubin JE; Butler WT; Sodek J
Biochem J; 1991 Feb; 273 ( Pt 3)(Pt 3):523-31. PubMed ID: 1996953
[TBL] [Abstract][Full Text] [Related]
20. Relevance of MicroRNA200 Family and MicroRNA205 for Epithelial to Mesenchymal Transition and Clinical Outcome in Biliary Tract Cancer Patients.
Urbas R; Mayr C; Klieser E; Fuereder J; Bach D; Stättner S; Primavesi F; Jaeger T; Stanzer S; Ress AL; Löffelberger M; Wagner A; Berr F; Ritter M; Pichler M; Neureiter D; Kiesslich T
Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27941621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
